191 related articles for article (PubMed ID: 35608442)
1. CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know-
Fernandes MC; Nikolovski I; Long Roche K; Lakhman Y
Radiology; 2022 Sep; 304(3):516-526. PubMed ID: 35608442
[TBL] [Abstract][Full Text] [Related]
2. High-Grade Serous Ovarian Cancer: Use of Machine Learning to Predict Abdominopelvic Recurrence on CT on the Basis of Serial Cancer Antigen 125 Levels.
Shinagare AB; Balthazar P; Ip IK; Lacson R; Liu J; Ramaiya N; Khorasani R
J Am Coll Radiol; 2018 Aug; 15(8):1133-1138. PubMed ID: 29789232
[TBL] [Abstract][Full Text] [Related]
3. Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?
Himoto Y; Cybulska P; Shitano F; Sala E; Zheng J; Capanu M; Nougaret S; Nikolovski I; Vargas HA; Wang W; Mueller JJ; Chi DS; Lakhman Y
Gynecol Oncol; 2019 Nov; 155(2):192-200. PubMed ID: 31521322
[TBL] [Abstract][Full Text] [Related]
4. A case of bilateral ovarian synchronous tumors (left ovarian serous papillary adenocarcinoma and right ovarian malignant mixed Müllerian tumor).
Song MJ; Lee CW; Seo KJ; Kim JA; Park JS; Hur SY
Eur J Gynaecol Oncol; 2011; 32(2):234-6. PubMed ID: 21614928
[TBL] [Abstract][Full Text] [Related]
5. Management of low-grade serous ovarian neoplasm in the setting of fertility preservation.
Marchocki Z; Rouzbahman M; Chawla T; May T
Int J Gynecol Cancer; 2020 Nov; 30(11):1834-1839. PubMed ID: 32759183
[No Abstract] [Full Text] [Related]
6. Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.
Chi DS; Barlin JN; Ramirez PT; Levenback CF; Mironov S; Sarasohn DM; Iyer RB; Dao F; Hricak H; Barakat RR
Int J Gynecol Cancer; 2010 Apr; 20(3):353-7. PubMed ID: 20375796
[TBL] [Abstract][Full Text] [Related]
7. Laparoendoscopic Single-site Surgery for Comprehensive Staging of Early Ovarian Cancer.
Chen S; Qi X; Chen L; Yi Q; Dong S; Xu L; Zheng Y
J Minim Invasive Gynecol; 2019; 26(5):806. PubMed ID: 30278233
[TBL] [Abstract][Full Text] [Related]
8. Total Infragastric Omentectomy Including the Vascular Perigastric Arcade in Patients With Advanced Serous Ovarian Tumors.
Cordeiro Vidal G; Croce S; Guyon F; Babin G; Querleu D
Int J Gynecol Cancer; 2017 Feb; 27(2):252-257. PubMed ID: 28114233
[TBL] [Abstract][Full Text] [Related]
9. Low-grade ovarian cancer in an adolescent patient.
Parker LP; Ramirez PT; Broaddus R; Sightler S; Wolf JK
Gynecol Oncol; 2001 Jan; 80(1):104-6. PubMed ID: 11136580
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
[TBL] [Abstract][Full Text] [Related]
11. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.
Fleming ND; Westin SN; Meyer LA; Shafer A; Rauh-Hain JA; Onstad M; Cobb L; Bevers M; Fellman BM; Burzawa J; Bhosale P; Zand B; Jazaeri A; Levenback C; Coleman RL; Soliman PT; Sood AK
Int J Gynecol Cancer; 2021 Jan; 31(1):92-97. PubMed ID: 33154095
[TBL] [Abstract][Full Text] [Related]
12. Serous psammocarcinoma of the ovary: an unusual finding.
Rettenmaier MA; Goldstein BH; Epstein HD; Brown JV; Micha JP
Gynecol Oncol; 2005 Nov; 99(2):510-1. PubMed ID: 16051342
[TBL] [Abstract][Full Text] [Related]
13. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
[TBL] [Abstract][Full Text] [Related]
14. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
15. The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.
Katsakhyan L; Baraban EG; Dumoff KL; Burger RA; Parikh R; Cooper K
Int J Gynecol Pathol; 2021 Mar; 40(2):175-179. PubMed ID: 32168063
[TBL] [Abstract][Full Text] [Related]
16. Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma.
Matsuo K; Tanabe K; Ikeda M; Shibata T; Kajiwara H; Miyazawa M; Miyazawa M; Hayashi M; Shida M; Hirasawa T; Roman LD; Mikami M
Arch Gynecol Obstet; 2018 Mar; 297(3):749-756. PubMed ID: 29340789
[TBL] [Abstract][Full Text] [Related]
17. Ovarian neuroendocrine carcinoma, non-small cell type, associated with serous carcinoma.
Choi YD; Lee JS; Choi C; Park CS; Nam JH
Gynecol Oncol; 2007 Mar; 104(3):747-52. PubMed ID: 17229461
[TBL] [Abstract][Full Text] [Related]
18. Concurrent ovarian serous carcinoma and osteogenesis imperfecta.
Nishida T; Oda T; Sugiyama T; Izumi S; Yakushiji M
Arch Gynecol Obstet; 1993; 253(3):153-6. PubMed ID: 8250604
[TBL] [Abstract][Full Text] [Related]
19. Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
Cohn DE; Hall NC; Povoski SP; Seamon LG; Farrar WB; Martin EW
Gynecol Oncol; 2008 Aug; 110(2):152-7. PubMed ID: 18539314
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma.
Lai J; Tong C; Chien JR
Anticancer Res; 2021 Sep; 41(9):4417-4422. PubMed ID: 34475063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
